Skip to content
Recall Observatory FDA recall evidence

Drug product

Neostigmine Methylsulfate Injection, USP, 4 mg/4 mL (1 mg/mL) syringe, packaged in 5 x 4 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-942-04

D-1271-2022

June 30, 2022

Class II

Product summary

Firm
Nephron Sterile Compounding Center LLC
Event
Event 90512
Status
Terminated
Classification
Class II
Quantity
10,700 syringes
Official record key
drug-enforcement:D-1271-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lots: NE2004A, Exp. 7/26/2022; NE2010A, Exp. 9/5/2022; NE2013A, Exp. 10/20/2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility